QQQ   419.93 (-0.82%)
AAPL   165.58 (-0.87%)
MSFT   402.29 (-0.49%)
META   490.73 (-2.21%)
GOOGL   155.13 (-0.56%)
AMZN   176.75 (-1.38%)
TSLA   150.09 (+0.11%)
NVDA   824.46 (-2.63%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.77 (-0.16%)
T   16.33 (+0.00%)
F   12.13 (+0.58%)
MU   109.43 (-2.23%)
GE   151.44 (-0.98%)
CGC   7.69 (-1.79%)
DIS   111.90 (-0.47%)
AMC   3.14 (+7.53%)
PFE   25.62 (+0.91%)
PYPL   62.21 (+0.18%)
XOM   120.34 (+1.54%)
QQQ   419.93 (-0.82%)
AAPL   165.58 (-0.87%)
MSFT   402.29 (-0.49%)
META   490.73 (-2.21%)
GOOGL   155.13 (-0.56%)
AMZN   176.75 (-1.38%)
TSLA   150.09 (+0.11%)
NVDA   824.46 (-2.63%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.77 (-0.16%)
T   16.33 (+0.00%)
F   12.13 (+0.58%)
MU   109.43 (-2.23%)
GE   151.44 (-0.98%)
CGC   7.69 (-1.79%)
DIS   111.90 (-0.47%)
AMC   3.14 (+7.53%)
PFE   25.62 (+0.91%)
PYPL   62.21 (+0.18%)
XOM   120.34 (+1.54%)
QQQ   419.93 (-0.82%)
AAPL   165.58 (-0.87%)
MSFT   402.29 (-0.49%)
META   490.73 (-2.21%)
GOOGL   155.13 (-0.56%)
AMZN   176.75 (-1.38%)
TSLA   150.09 (+0.11%)
NVDA   824.46 (-2.63%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.77 (-0.16%)
T   16.33 (+0.00%)
F   12.13 (+0.58%)
MU   109.43 (-2.23%)
GE   151.44 (-0.98%)
CGC   7.69 (-1.79%)
DIS   111.90 (-0.47%)
AMC   3.14 (+7.53%)
PFE   25.62 (+0.91%)
PYPL   62.21 (+0.18%)
XOM   120.34 (+1.54%)
QQQ   419.93 (-0.82%)
AAPL   165.58 (-0.87%)
MSFT   402.29 (-0.49%)
META   490.73 (-2.21%)
GOOGL   155.13 (-0.56%)
AMZN   176.75 (-1.38%)
TSLA   150.09 (+0.11%)
NVDA   824.46 (-2.63%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.77 (-0.16%)
T   16.33 (+0.00%)
F   12.13 (+0.58%)
MU   109.43 (-2.23%)
GE   151.44 (-0.98%)
CGC   7.69 (-1.79%)
DIS   111.90 (-0.47%)
AMC   3.14 (+7.53%)
PFE   25.62 (+0.91%)
PYPL   62.21 (+0.18%)
XOM   120.34 (+1.54%)
Free Trial

Medical Properties Trust (MPW) Stock Forecast & Price Target

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free mpw Stock Alerts
$4.70
-0.14 (-2.89%)
(As of 10:51 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Medical Properties Trust Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Reduce
Based on 13 Analyst Ratings

Analysts' Consensus Price Target

$5.75
22.34% Upside
High Forecast$10.00
Average Forecast$5.75
Low Forecast$4.00
TypeCurrent Forecast
4/20/23 to 4/19/24		1 Month Ago
3/21/23 to 3/20/24		3 Months Ago
1/20/23 to 1/20/24		1 Year Ago
4/20/22 to 4/20/23
Consensus Rating
Reduce
Reduce
Reduce
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
Hold
6 Hold rating(s)
4 Hold rating(s)
6 Hold rating(s)
7 Hold rating(s)
Sell
4 Sell rating(s)
5 Sell rating(s)
4 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$5.75$6.59$8.50$13.33
Predicted Upside22.34% Upside23.30% Upside32.21% Upside26.15% Upside
Get Medical Properties Trust Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MPW and its competitors with MarketBeat's FREE daily newsletter.

MPW Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MPW Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Medical Properties Trust Stock vs. The Competition

TypeMedical Properties TrustFinance CompaniesS&P 500
Consensus Rating Score
1.92
2.44
2.49
Consensus RatingReduceHoldHold
Predicted Upside14.77% Upside77.92% Upside12.31% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/17/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeSell ➝ Hold$2.00 ➝ $5.00+4.17%
4/10/2024Colliers Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Neutral$10.00 ➝ $4.25-0.47%
4/8/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetHold ➝ Hold$4.00 ➝ $4.50+11.11%
3/1/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral ➝ Outperform$6.00+42.69%
2/20/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOutperform ➝ Outperform$8.00 ➝ $5.00+39.66%
1/5/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOverweight ➝ Sector Weight
1/3/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetNeutral ➝ Neutral$9.00 ➝ $7.00+38.34%
11/29/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetUnderweight ➝ Underweight$8.00 ➝ $5.00+3.31%
11/10/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Hold$12.00 ➝ $4.50-3.12%
10/16/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeEqual Weight ➝ Underweight$7.00 ➝ $4.00-19.35%
8/22/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOverweight ➝ Overweight$12.00 ➝ $10.00+42.65%
8/11/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeStrong-Buy ➝ Underperform
8/11/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeNeutral ➝ Underperform$9.00 ➝ $8.00-1.60%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 11:10 AM ET.

MPW Price Target - Frequently Asked Questions

What is Medical Properties Trust's consensus rating and price target?

According to the issued ratings of 13 analysts in the last year, the consensus rating for Medical Properties Trust stock is Reduce based on the current 4 sell ratings, 6 hold ratings and 3 buy ratings for MPW. The average twelve-month price prediction for Medical Properties Trust is $5.75 with a high price target of $10.00 and a low price target of $4.00. Learn more on MPW's analyst rating history.

Do Wall Street analysts like Medical Properties Trust more than its competitors?

Analysts like Medical Properties Trust less than other Finance companies. The consensus rating for Medical Properties Trust is Reduce while the average consensus rating for finance companies is Hold. Learn more on how MPW compares to other companies.

Is Medical Properties Trust being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Medical Properties Trust's stock had 2 upgrades and 1 downgrade by analysts.

Does Medical Properties Trust's stock price have much upside?

According to analysts, Medical Properties Trust's stock has a predicted upside of 13.86% based on their 12-month stock forecasts.

What analysts cover Medical Properties Trust?

Medical Properties Trust has been rated by BNP Paribas, Colliers Securities, Deutsche Bank Aktiengesellschaft, Royal Bank of Canada, and Truist Financial in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NYSE:MPW) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research